Clinical Trials

450 enrolled

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT07402109 2026-02-11

CT-STARRS

40 enrolled

Carcinoma, Renal Cell

NCT07351266 2026-01-20

Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors

10 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07346404 2026-01-16

RUBIKID

50 enrolled

Carcinoma, Renal Cell, Neovascularization, Pathologic

NCT06770855 2026-01-09

Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)

23 enrolled

Carcinoma, Renal Cell

NCT07321197 2026-01-06

RECLND

220 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07277972 2025-12-11

Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy

36 enrolled

Carcinoma, Renal Cell

NCT07233668 2025-12-03

IVE in mRCC

172 enrolled

Carcinoma, Renal Cell

NCT07256223 2025-12-01

A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

30 enrolled

Phase 1 Not yet recruiting

Carcinoma, Renal Cell

NCT07252661 2025-11-28

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

40 enrolled

DermatologicEndocrineGastrointestinalGenitourinaryHead & Neck

Thyroid cancer, medullary, Carcinoma, Renal Cell, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis

NCT07246759 2025-11-24

NEUTROFLOW

BreastDermatologicGenitourinaryHead & NeckThoracic

600 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT07226544 2025-11-10

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

31 enrolled

Carcinoma, Renal Cell

NCT07218692 2025-10-20

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

35 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07197580 2025-09-29

LUTEON

40 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms, Recurrence

NCT07037004 2025-09-23

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

62 enrolled

Phase 1 Not yet recruiting

Carcinoma, Renal Cell

NCT07187869 2025-09-23

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

16 enrolled

Carcinoma, Renal Cell

NCT07165418 2025-09-10

A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

116 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Carcinoma, Renal Cell

NCT06708936 2025-09-03

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

12 enrolled

Carcinoma, Renal Cell

NCT07087158 2025-07-28

A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma

30 enrolled

Carcinoma, Renal Cell

NCT07043608 2025-07-02

ZAMBONI

20 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT07023432 2025-06-17

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

78 enrolled

Carcinoma, Renal Cell

NCT07004426 2025-06-11

KIDCaD

1,000 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06960174 2025-05-07

Virtual Renality: Assessing the Impact of Virtual Reality on Preoperative Planning in Renal Cancer Surgery

70 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06773377 2025-01-14

Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma

77 enrolled

Carcinoma, Renal Cell

NCT06585878 2024-09-19

A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma

60 enrolled

Phase 1/2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06577961 2024-08-29

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

37 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06523049 2024-07-26

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

67 enrolled

Carcinoma, Renal Cell

NCT06146777 2023-11-29

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

468 enrolled

Carcinoma, Renal Cell

NCT06093568 2023-10-23

Delving Into Participation Trends in Renal Cell Carcinoma Studies

500 enrolled

Carcinoma, Renal Cell

NCT05941169 2023-07-12

PrimerX

750 enrolled

Phase 1/2 Not yet recruiting

Carcinoma, Renal Cell

NCT05798455 2023-04-04

Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma

30 enrolled